# 18F-DCFPyL PET/CT in Hepatocellular Carcinoma

> **NCT05009979** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 8 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** F18-FDG
- **DEVICE:** MRI
- **DEVICE:** CT
- **DRUG:** F18-DCFPyL
- **PROCEDURE:** Tumor biopsy

## Key facts

- **NCT ID:** NCT05009979
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-18
- **Primary completion:** 2024-11-14
- **Final completion:** 2024-11-20
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Reason for termination was a combination of slow accrual in setting of austerity measures regarding resource allocation.
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05009979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05009979, "18F-DCFPyL PET/CT in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05009979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*